Annual Net Income
-$160.93 M
+$120.79 M+42.88%
December 31, 2023
Summary
- As of February 7, 2025, FATE annual net profit is -$160.93 million, with the most recent change of +$120.79 million (+42.88%) on December 31, 2023.
- During the last 3 years, FATE annual net income has risen by +$12.46 million (+7.19%).
- FATE annual net income is now -1098.54% below its all-time high of -$13.43 million, reached on December 31, 2011.
Performance
FATE Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Net Income
-$47.68 M
-$9.25 M-24.07%
September 30, 2024
Summary
- As of February 7, 2025, FATE quarterly net profit is -$47.68 million, with the most recent change of -$9.25 million (-24.07%) on September 30, 2024.
- Over the past year, FATE quarterly net income has dropped by -$2.51 million (-5.55%).
- FATE quarterly net income is now -1243.80% below its all-time high of -$3.55 million, reached on March 31, 2013.
Performance
FATE Quarterly Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Net Income
-$178.23 M
-$2.51 M-1.43%
September 30, 2024
Summary
- As of February 7, 2025, FATE TTM net profit is -$178.23 million, with the most recent change of -$2.51 million (-1.43%) on September 30, 2024.
- Over the past year, FATE TTM net income has dropped by -$5.06 million (-2.92%).
- FATE TTM net income is now -4233.36% below its all-time high of -$4.11 million, reached on September 30, 2012.
Performance
FATE TTM Net Income Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Net Income Formula
Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses
FATE Net Income Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +42.9% | -5.5% | -2.9% |
3 y3 years | +7.2% | -152.5% | +24.1% |
5 y5 years | -141.6% | -42.2% | -59.3% |
FATE Net Income Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +42.9% | -152.5% | +42.9% | -10.8% | +39.4% |
5 y | 5-year | -64.0% | +42.9% | -152.5% | +42.9% | -81.6% | +39.4% |
alltime | all time | -1098.5% | +42.9% | -1243.8% | +42.9% | -4233.4% | +39.4% |
Fate Therapeutics Net Income History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$47.68 M(+24.1%) | -$178.23 M(+1.4%) |
Jun 2024 | - | -$38.43 M(-20.0%) | -$175.72 M(-7.5%) |
Mar 2024 | - | -$48.00 M(+8.8%) | -$190.05 M(+18.1%) |
Dec 2023 | -$160.93 M(-42.9%) | -$44.12 M(-2.3%) | -$160.93 M(-7.1%) |
Sep 2023 | - | -$45.17 M(-14.4%) | -$173.17 M(-18.1%) |
Jun 2023 | - | -$52.76 M(+179.4%) | -$211.56 M(-9.9%) |
Mar 2023 | - | -$18.88 M(-66.5%) | -$234.91 M(-16.6%) |
Dec 2022 | -$281.72 M(+32.8%) | -$56.36 M(-32.6%) | -$281.72 M(-4.2%) |
Sep 2022 | - | -$83.56 M(+9.8%) | -$293.98 M(+15.9%) |
Jun 2022 | - | -$76.11 M(+15.9%) | -$253.72 M(+9.0%) |
Mar 2022 | - | -$65.69 M(-4.3%) | -$232.75 M(+9.7%) |
Dec 2021 | -$212.15 M(+22.4%) | -$68.62 M(+58.4%) | -$212.15 M(+7.9%) |
Sep 2021 | - | -$43.31 M(-21.4%) | -$196.64 M(-7.3%) |
Jun 2021 | - | -$55.13 M(+22.3%) | -$212.02 M(+14.6%) |
Mar 2021 | - | -$45.09 M(-15.1%) | -$184.96 M(+6.7%) |
Dec 2020 | -$173.39 M(+76.7%) | -$53.11 M(-9.5%) | -$173.39 M(+16.7%) |
Sep 2020 | - | -$58.68 M(+109.0%) | -$148.58 M(+27.5%) |
Jun 2020 | - | -$28.07 M(-16.3%) | -$116.50 M(+4.1%) |
Mar 2020 | - | -$33.52 M(+18.4%) | -$111.91 M(+14.0%) |
Dec 2019 | -$98.15 M(+47.4%) | -$28.30 M(+6.4%) | -$98.15 M(+14.3%) |
Sep 2019 | - | -$26.61 M(+13.3%) | -$85.87 M(+12.9%) |
Jun 2019 | - | -$23.48 M(+18.8%) | -$76.05 M(+5.3%) |
Mar 2019 | - | -$19.76 M(+23.3%) | -$72.22 M(+8.4%) |
Dec 2018 | -$66.60 M | -$16.03 M(-4.5%) | -$66.60 M(+5.6%) |
Sep 2018 | - | -$16.78 M(-14.6%) | -$63.07 M(+10.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2018 | - | -$19.65 M(+39.0%) | -$56.97 M(+21.3%) |
Mar 2018 | - | -$14.13 M(+13.1%) | -$46.96 M(+9.3%) |
Dec 2017 | -$42.95 M(+28.4%) | -$12.50 M(+17.0%) | -$42.95 M(+11.9%) |
Sep 2017 | - | -$10.68 M(+10.8%) | -$38.40 M(+5.3%) |
Jun 2017 | - | -$9.64 M(-4.8%) | -$36.45 M(+3.5%) |
Mar 2017 | - | -$10.13 M(+27.5%) | -$35.21 M(+5.2%) |
Dec 2016 | -$33.46 M(+11.6%) | -$7.94 M(-9.1%) | -$33.46 M(+1.5%) |
Sep 2016 | - | -$8.74 M(+3.9%) | -$32.97 M(+5.9%) |
Jun 2016 | - | -$8.41 M(+0.4%) | -$31.12 M(+2.1%) |
Mar 2016 | - | -$8.38 M(+12.5%) | -$30.49 M(+1.7%) |
Dec 2015 | -$29.99 M(+15.9%) | -$7.45 M(+8.1%) | -$29.99 M(+4.2%) |
Sep 2015 | - | -$6.89 M(-11.5%) | -$28.78 M(+1.0%) |
Jun 2015 | - | -$7.78 M(-1.3%) | -$28.50 M(+6.4%) |
Mar 2015 | - | -$7.88 M(+26.4%) | -$26.78 M(+3.5%) |
Dec 2014 | -$25.88 M(+23.9%) | -$6.23 M(-5.6%) | -$25.88 M(+1.9%) |
Sep 2014 | - | -$6.60 M(+8.8%) | -$25.39 M(+2.1%) |
Jun 2014 | - | -$6.07 M(-13.1%) | -$24.86 M(+2.2%) |
Mar 2014 | - | -$6.98 M(+21.6%) | -$24.33 M(+16.4%) |
Dec 2013 | -$20.89 M(+46.7%) | -$5.74 M(-5.5%) | -$20.89 M(+8.2%) |
Sep 2013 | - | -$6.07 M(+9.7%) | -$19.31 M(+11.3%) |
Jun 2013 | - | -$5.53 M(+56.0%) | -$17.35 M(+46.8%) |
Mar 2013 | - | -$3.55 M(-14.6%) | -$11.82 M(+42.9%) |
Dec 2012 | -$14.24 M(+6.0%) | -$4.16 M(+1.0%) | -$8.27 M(+101.0%) |
Sep 2012 | - | -$4.11 M | -$4.11 M |
Dec 2011 | -$13.43 M | - | - |
FAQ
- What is Fate Therapeutics annual net profit?
- What is the all time high annual net income for Fate Therapeutics?
- What is Fate Therapeutics annual net income year-on-year change?
- What is Fate Therapeutics quarterly net profit?
- What is the all time high quarterly net income for Fate Therapeutics?
- What is Fate Therapeutics quarterly net income year-on-year change?
- What is Fate Therapeutics TTM net profit?
- What is the all time high TTM net income for Fate Therapeutics?
- What is Fate Therapeutics TTM net income year-on-year change?
What is Fate Therapeutics annual net profit?
The current annual net income of FATE is -$160.93 M
What is the all time high annual net income for Fate Therapeutics?
Fate Therapeutics all-time high annual net profit is -$13.43 M
What is Fate Therapeutics annual net income year-on-year change?
Over the past year, FATE annual net profit has changed by +$120.79 M (+42.88%)
What is Fate Therapeutics quarterly net profit?
The current quarterly net income of FATE is -$47.68 M
What is the all time high quarterly net income for Fate Therapeutics?
Fate Therapeutics all-time high quarterly net profit is -$3.55 M
What is Fate Therapeutics quarterly net income year-on-year change?
Over the past year, FATE quarterly net profit has changed by -$2.51 M (-5.55%)
What is Fate Therapeutics TTM net profit?
The current TTM net income of FATE is -$178.23 M
What is the all time high TTM net income for Fate Therapeutics?
Fate Therapeutics all-time high TTM net profit is -$4.11 M
What is Fate Therapeutics TTM net income year-on-year change?
Over the past year, FATE TTM net profit has changed by -$5.06 M (-2.92%)